Adaptive Survival Trials
Dominic Magirr, Thomas Jaki, Franz Koenig, Martin Posch

TL;DR
This paper addresses the challenge of designing adaptive survival trials with time-to-event endpoints, proposing a new method that incorporates all event times to improve accuracy while controlling error rates.
Contribution
It introduces an alternative test for adaptive survival trials that includes all event times, enhancing the analysis of long-term survival data.
Findings
The proposed method controls type I error effectively.
It improves the use of interim data in survival analysis.
Application to cancer therapy trial demonstrates practical benefits.
Abstract
Mid-study design modifications are becoming increasingly accepted in confirmatory clinical trials, so long as appropriate methods are applied such that error rates are controlled. It is therefore unfortunate that the important case of time-to-event endpoints is not easily handled by the standard theory. We analyze current methods that allow design modifications to be based on the full interim data, i.e., not only the observed event times but also secondary endpoint and safety data from patients who are yet to have an event. We show that the final test statistic may ignore a substantial subset of the observed event times. Since it is the data corresponding to the earliest recruited patients that is ignored, this neglect becomes egregious when there is specific interest in learning about long-term survival. An alternative test incorporating all event times is proposed, where a…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsStatistical Methods in Clinical Trials · Optimal Experimental Design Methods · Statistical Methods and Inference
